Basics Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.64B Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 3.29% Avg Daily Range (30 D): $0.49 | 3.38% Avg Daily Range (90 D): $0.34 | 2.66% Institutional Daily Volume Avg Daily Volume: 1.06M Avg Daily Volume (30 D): 1.65M Avg Daily Volume (90 D): 1.67M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 2,687 Avg Inst. Trade: $1.91M Avg Inst. Trade (30 D): $2.65M Avg Inst. Trade (90 D): $2.51M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $3.6M Avg Closing Trade (90 D): $3.51M Avg Closing Volume: 143.27K     News Aug 6, 2025 @ 11:01 PM Why Adaptive Biotechnologies Stock Popped by Almos... Source: Eric Volkman Jul 25, 2025 @ 8:59 AM U.S. Minimal Residual Disease Testing Market Trend... Source: Researchandmarkets.Com May 30, 2025 @ 11:30 AM Adaptive Biotechnologies Highlights New Data at 20... Source: Adaptive Biotechnologies Corporation Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.17 $-.2 Diluted EPS $-.17 $-.2 Revenue $ $ 58.88M $ 52.44M Gross Profit $ $ 40.88M $ 35.46M Net Income / Loss $ $ -25.59M $ -29.83M Operating Income / Loss $ $ -25.04M $ -29.6M Cost of Revenue $ $ 18M $ 16.98M Net Cash Flow $ $ -7.47M $ 2.54M PE Ratio